Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06523803
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-22
Brief Title:
A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1 Open-label Multicenter Study of ZW171 in Participants With Advanced or Metastatic Ovarian Cancer Non-small Cell Lung Cancer NSCLC and Other Mesothelin Expressing Cancers
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being done to find out if ZW171 is safe and can treat participants with advanced locally advanced inoperable andor metastatic mesothelin-expressing cancers
Detailed Description:
Part 1 of the study will evaluate the safety and tolerability of ZW171 Part 2 of the study will evaluate the anti-tumor activity of ZW171 while continuing to evaluate the safety and tolerability
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None